Current Opinion in Nephrology and Hypertension

Article	Citations
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	31
Dual organ transplantation: Pancreas and Liver in the kidney axis	31
Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes	29
The impact of conflicts on patients with chronic kidney disease	29
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	24
The clinical application of frailty in nephrology and transplantation	22
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	21
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	20
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	19
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	19
Editorial introductions	19
Interferon gamma in the pathogenesis of hypertension − recent insights	18
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	17
Prediction models for earlier stages of chronic kidney disease	17
International equity in access to home dialysis	17
Editorial introduction	17
Maximizing opportunities for kidney transplantation in older adults	17
Renal denervation for the treatment of hypertension and kidney disease	16
Modern indications for referral for kidney and pancreas transplantation	15
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	15
Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population	15
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	15
Bringing the end-stage kidney disease life plan home	14
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	14
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	14

The race coefficient in glomerular filtration rate-estimating equations and its removal	13
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	13
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	12
Built environment and chronic kidney disease: current state and future directions	12
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	12
Plant-based diets for kidney disease prevention and treatment	12
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	11
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	10
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	10
Editorial: One size does not fit all: moving toward individualized therapy	10
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	10
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	10
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	9
Combination therapy with kidney protective therapies: optimizing the benefits?	9
Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one	9
Lipocalin-2: a novel link between the injured kidney and the bone	9
Complement detection in kidney biopsies – utility and challenges	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	9
Editorial introductions	9
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	9
Understanding renal phosphate handling: unfinished business	9
Automation and innovation in home hemodialysis machines	8
Editorial: Advancements in the management of kidney disease and electrolyte derangements	8
Impact of intensive blood pressure control on kidney outcomes	8
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease	8
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	8
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	8
Climate change and kidney stones	8
Cancer drugs and acute kidney injury: new therapies and new challenges	8
The current therapeutic approach for anaemia after kidney transplant	8
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	8
Noninvasive continuous intradialytic blood pressure monitoring: the key to improving haemodynamic stability	8
When the earth shakes unexpectedly: impact on nephrology services and patients	8
Deep learning applications for kidney histology analysis	8
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Editorial introduction	7
Evolving thresholds for the diagnosis of acute T cell mediated rejection	7
Hypernatremia in the intensive care unit	7
Sex differences in renal electrolyte transport	7
Contemporary risk prediction models in chronic kidney disease: when less is more	7
Recent advances in dialysis membranes	7
Prospects for gene therapy in polycystic kidney disease	7
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	7
Editorial introductions	7
New insights into renal calcium-sensing receptor activation	7
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	7
Renal osteodystrophy: something old, something new, something needed	7
New and old approaches to nutritional management of acute and chronic glomerulonephritis	7
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	7

Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	6
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
Screening for chronic kidney disease: change of perspective and novel developments	6
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	6
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis	6
Renal denervation: recent developments in clinical and preclinical research	6
Building kidney organoids from pluripotent stem cells	6
Novel intestinal dialysis interventions and microbiome modulation to control uremia	6
Evolving indications and management patterns in heart – kidney transplantation	6
Novel agents for treating IgA nephropathy	5
Chronic kidney disease and sex dimorphism	5
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
New guidelines and therapeutic updates for the management of lupus nephritis	5
The « race » correction in estimating glomerular filtration rate: an European point of view	5
Effects of aging on chronic kidney disease mineral and bone disorder	5
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	5
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	5
Novel approaches in antihypertensive pharmacotherapeutics	5
New therapeutics for primary hyperoxaluria type 1	5
Population health strategies for health equity in chronic kidney disease management	5
An update on corticosteroid treatment for IgA nephropathy	5
Cystatin C should be routinely available for estimating kidney function	5
The changing trajectory of diabetic kidney disease	5
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	5
The genetics of cystinuria – an update and critical reevaluation	5
Targeting inflammation in hypertension	5
Fibroblast growth factor 23 as a risk factor for incident diabetes	5
The potential of artificial intelligence-based applications in kidney pathology	5
Efficacy and safety of Sodium-Glucose-Transporter-2 inhibitors in kidney transplant patients	4
Climate crisis and nephrology: a review of climate change's impact on nephrology and how to combat it	4
Literature review: are NSAIDs harmful and is acetaminophen well tolerated?	4
The role of osteopontin in chronic kidney disease-mineral bone disorder	4
Updated diagnostic and therapeutic management for membranous nephropathy	4
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	4
Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension	4
Editorial introduction	4
Fifty years of basic and clinical renal stone research: have we achieved major breakthroughs? A debate	4
Editorial: Narrow the gap, build a bridge: an inspirational approach to chronic kidney disease–mineral and bone disorder	4
Progress in the management of patients with diabetes and chronic kidney disease	4
Agents to treat osteoporosis in chronic kidney disease	4
Phosphate sensing in health and disease	4
Editorial introductions	4
Glomerular filtration rate and sexual dimorphism: lessons from animal and human studies	4
COVID-19 in patients with glomerular disease	4
Editorial introductions	4
Electrolytes disturbances in cancer patients	4
The promise of artificial intelligence for kidney pathophysiology	4
Editorial introductions	4
Postnatal renal tubule development: roles of tubular flow and flux	4
Home dialysis: there's no place like home	4
Climate change and its influence in nephron mass	4
Insights into proliferative glomerulonephritis with monoclonal immunoglobulin deposits – is it really monoclonal or not?	4
The role of calprotectin in vascular calcification	4
WNK1 in the kidney	4
Mendelian randomization and the association of fibroblast growth factor-23 with heart failure with preserved ejection fraction	4
Implications of climate change on acute kidney injury	3
Social and humanitarian issues in nephrology and hypertension	3
Targeting aldosterone to improve cardiorenal outcomes: from nonsteroidal mineralocorticoid receptor antagonists to aldosterone synthase inhibitors	3
Let's stop talking about ‘citrate toxicity’	3
Novel pharmacological interventions for diabetic kidney disease	3
Skin autofluorescence as tool for cardiovascular and diabetes risk prediction	3
Pruritus in chronic kidney disease	3
Centering marginalized voices in advocacy for equitable policy change in kidney disease	3
Novel insights in the regulation of intercalated cell differentiation	3
Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation	3
Editorial introductions	3
Challenges in standardizing preimplantation kidney biopsy assessments and the potential of AI-Driven solutions	3
Heating up: climate change and the threat to human health	3
Cellular and molecular interrogation of kidney biopsy specimens	3
Kidney health and function with left ventricular assist devices	3
Editorial introductions	3
Role of artificial intelligence in the diagnosis and management of kidney disease: applications to chronic kidney disease and acute kidney injury	3
The times they are K+-changin’: bringing the potassium curriculum out of the 20th century	3
Updates on renal phosphate transport	3
Indications for and results of renal autotransplantation	3
Factors that lead to dialysis as the preferred treatment modality for patients with chronic kidney disease	3
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker	3
Applications of cardiac biomarkers in chronic kidney disease	3
Justifying access to kidney care in low resource and humanitarian settings	3

Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy	3
Community acquired and hospital acquired AKI - two diseases divided by a common definition	3
Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide	3
Persistent hyperparathyroidism in long-term kidney transplantation: time to consider a less aggressive approach	3
Editorial introductions	3
Use of water in dialysis and its impact on the environment	3
Fibroblast growth factor 23, klotho and heparin	3
Harm! foul! How acute kidney injury SHReDDs patient futures	2
Vasopressin, protein metabolism, and water conservation	2
The TMEM16A channel as a potential therapeutic target in vascular disease	2
Treatment potential in APOL1-associated nephropathy	2
Gene therapy for kidney disease: targeting cystinuria	2
Enabling flourishing: novel approaches in palliative medicine for children with advanced kidney disease	2
Immune checkpoint inhibitors and kidney disease	2
Citrate in autosomal dominant polycystic kidney disease: biomarker or therapeutic agent?	2
How to assess quality of life in persons with chronic kidney disease	2
Novel indications for referral and care for simultaneous liver kidney transplant recipients	2
Contribution of phosphate and FGF23 to CKD progression	2
Chronic kidney disease with unknown cause across the global spectrum	2
Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients	2
Recent advances in the understanding of the peritoneal membrane	2
The genetic spectrum of Gitelman(-like) syndromes	2
A review of the AURORA and BLISS trials: will it revolutionize the treatment of lupus nephritis?	2
Type 4 renal tubular acidosis and uric acid nephrolithiasis: two faces of the same coin?	2
Complications after native kidney biopsy: definitive data	2
Hypertension in Pregnancy: What We Now Know	2
Editorial introductions	2
Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review	2
APOL1 nephropathy – a population genetics success story	2
Optimizing renin–angiotensin–aldosterone inhibition in advanced chronic kidney disease: balancing benefits and risks	2
Revisiting the relationship between (Pro)Renin receptor and the intrarenal RAS: focus on the soluble receptor	2
Do not forget about transplant patients during disasters	2
Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection	2
Lysine and salt-sensitive hypertension	2
The cardiovascular unphysiology of thrice weekly hemodialysis	2
Metabolic dysfunction associated steatotic liver and kidney stones: what is going on?	2
Can chronic kidney disease lead to chronic heart failure, and does worsening chronic heart failure lead to chronic kidney disease progression	2
Moving beyond the syndrome: how can acute kidney injury phenotypes help?	2
Depression in dialysis	2
Quality of life in people with chronic kidney disease: focusing on modifiable risk factors	2
Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder	2
KCa3.1 in diabetic kidney disease	2
Uromodulin: more than a marker for chronic kidney disease progression	2
Kidney function assessment in the geriatric population	2
Editorial introductions	2
APOL1-associated kidney disease: modulators of the genotype-phenotype relationship	2